Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019

Nov 05 2019

• By Joanne S. Eglovitch

Warning Rubber Stamp — FDA Investigators Focused On Uninspected Inventory In FY 2019 • Source: Shutterstock

Related Content

FDA Warning Letters Hit Three Repackers For Failing To Identify Original API Makers

Jul 03 2019

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

May 07 2007

Warning Letters Mount As FDA Completes Initial Inspections Of Under-The-Radar Facilities

Jun 11 2018

Additional Topics

United States Manufacturing Quality Enforcement OTC Drugs BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.